Investor Presentation Q1 2018

Investor contact information Investor Presentation First three months of 2018 Slide 19 Share information Novo Nordisk's B shares are listed on the stock exchange in Copenhagen under the symbol 'NOVO B'. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For further company information, visit Novo Nordisk on the internet at: novonordisk.com 24 Jun 2018 08 Aug 2018 01 Nov 2018 01 Feb 2019 Upcoming events American Diabetes Association investor presentation Financial statement for the first six months of 2018 Financial statement for the first nine months of 2018 Financial statement for 2018 Investor Relations contacts Novo Nordisk A/S Investor Relations Novo Allé, DK-2880 Bagsværd Peter Hugreffe Ankersen +45 3075 9085 [email protected] Anders Mikkelsen +45 3079 4461 Christina Kjær +45 3079 3009 [email protected] [email protected] changing diabetes novo nordisk

View entire presentation